FreeTCCL Archive Anamorelin Increases Body Mass in Two Global Phase III Trials October 30, 2014Vol.37 No.10
FreeTCCL Archive Zytiga and Prednisone Extends Overall Survival in mCRPC Trial October 30, 2014Vol.37 No.10
FreeTCCL Archive Afatinib Delays Tumor Growth in LUX-Head and Neck 1 Study October 30, 2014Vol.37 No.10
FreeTCCL Archive Study: Angiopoietin-2 Levels May Predict Lenvatinib Response October 30, 2014Vol.37 No.10
FreeTCCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 30, 2014Vol.37 No.10
FreeTCCL Archive Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial October 30, 2014Vol.37 No.10
FreeIn Brief Stand Up To Cancer epigenetics dream team receives $7.5 million from Van Andel Research Institute October 24, 2014Vol.40 No.40
FreeIn Brief Association of Community Cancer Centers receives gift from Bristol-Myers Squibb October 24, 2014Vol.40 No.40
FreeIn Brief Northwestern Mutual and Alex’s Lemonade Stand fund eight young investigators October 24, 2014Vol.40 No.40
